A powerful congressional committee has voted to prevent federal employees from having medical marijuana covered under their workers’ compensation programs—regardless of the Trump administration’s move to reschedule cannabis.
On Tuesday, the House Appropriations Committee approved a Fiscal Year 2027 bill covering Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) in a vote of 34-28. In addition to including the medical cannabis and workers’ comp provision, the legislation and an attached report also addresses other drug policy issues such as overdose prevention centers and a health condition experienced by some marijuana consumers.
One section of the Labor-HHS bill says that no funding provided to the Department of Labor under the measure can be used to “authorize, provide, reimburse, or otherwise recognize marijuana or any cannabis-derived substance as a compensable medical treatment or benefit” under any federal workers’ compensation program—”regardless of any change in the scheduling of marijuana” under the Controlled Substances Act (CSA).
“SEC. 532. None of the funds made available by this Act may be used by the Department of Labor, including the Office of Workers’ Compensation Programs, to authorize, provide, reimburse, or otherwise recognize marijuana or any cannabis-derived substance as a compensable medical treatment or benefit under
Read full article on Marijuana Moment
